Scanning for cancer treatment

(Harvard University) 11,000 people are predicted to die from acute myeloid leukemia (AML) in 2019. Recently, drug developers designed a new treatment to target the cancer's mutated genes. But, these drugs don't always work. Now, in a new study, researchers investigate both sides of the drug-body relationship to better understand why certain AML treatments--and other cancer treatments--may not work as expected.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news